Drugs Made In America Acquisition Corp.
DMAAR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Drugs Made In America Acquisition Corp. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 35 | 28 | −7 |
| Shares | 14.8M | 11.6M | −3.18M (−21.5%) |
| Value | $872.3K | $1.27M | +$402.4K (+46.1%) |
New holders (2)
Institutions that held Drugs Made In America Acquisition Corp. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T3 Companies, LLC | 15,000 | $1.65K | 0.00% |
| UBS Group AG | 108 | $12 | 0.00% |
Sold out (9)
Institutions that held Drugs Made In America Acquisition Corp. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| RLH Capital LLC | 399,391 | $24.1K |
| Glazer Capital, LLC | 297,475 | $18.0K |
| Aristeia Capital LLC | 264,168 | $16.0K |
| Quarry LP | 249,391 | $15.1K |
| Meteora Capital, LLC | 182,581 | $11.0K |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 117,544 | $7.05K |
| Verition Fund Management LLC | 99,200 | $5.47K |
| Bulldog Investors, LLP | 43,364 | $2.62K |
| StoneX Group Inc. | 42,120 | $2.54K |